A Fast-Track Overhaul of Drug Development Processes at AstraZeneca

As an organization grows over years, processes diverge. At APQC's 2022 Process and Knowledge Management Conference, AstraZeneca’s Business Process Manager Christopher Moriak described how the global pharmaceutical company reinvented its drug development process in just one year. By standardizing to a single clinical trials process for every drug in development, AstraZeneca was able to ensure regulatory compliance, increase resource flexibility, stay ahead of competitors, and reduce training time.

This is a summary of the session; click here for a copy of the presentation.